Business & Regulation

Antibiotics were once hailed as wonder drugs in the war against infection, but now it looks like bacteria might have the upper hand. How can we turn the tide?

An FDA Warning Letter can be a real wake up call. How can you address the root of the problem?

Sitting Down With… Wim Leereveld, founder and CEO of the Access to Medicine Foundation

The World Health Organization has compiled a list of 17 tropical diseases that deserve higher priority.

After years of intense criticism, the European Parliament has adopted a new regulation for clinical trials that will replace the current EU Clinical Trials Directive by mid-2016.

Lilly and Sanofi go head-to-head on a diabetes drug. Meanwhile, Hospira sues the FDA over a new generic approval.

European Commission (EC) plans to transfer governance of the medicines dossier from health to enterprise has upset public health NGOs.

Top food and pharma fugitives are named and shamed.

If you work in the development or manufacture of drugs and biologics – this is your magazine.